Indivior PLC (NASDAQ:INDV) Stock Now Rated “Moderate Buy” by Sell-Side Analysts

Shares of Indivior PLC (NASDAQ:INDV) have received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $45.17.

INDV has been the subject of several research reports. Craig Hallum reaffirmed a “buy” rating and issued a $53.00 price target on shares of Indivior in a research report on Tuesday, August 4th. Zacks Research downgraded shares of Indivior from a “strong-buy” rating to a “hold” rating in a research note on Monday, June 29th. Barclays cut their price objective on shares of Indivior from $46.00 to $43.00 and set an “overweight” rating on the stock in a report on Wednesday, August 5th. Finally, Weiss Ratings downgraded shares of Indivior from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday.

Insider Buying and Selling at Indivior

In related news, insider Christian Heidbreder sold 18,586 shares of the company’s stock in a transaction on Friday, July 10th. The stock was sold at an average price of $41.14, for a total transaction of $764,628.04. Following the completion of the sale, the insider directly owned 209,337 shares in the company, valued at $8,612,124.18. This represents a 8.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Woodrow D. Anderson acquired 1,500 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were bought at an average cost of $35.69 per share, for a total transaction of $53,535.00. Following the transaction, the chief accounting officer owned 27,638 shares of the company’s stock, valued at $986,400.22. This represents a 5.74% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.74% of the company’s stock.

Institutional Trading of Indivior

Hedge funds have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Indivior by 72.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,093 shares of the company’s stock valued at $39,000 after buying an additional 460 shares in the last quarter. Rockefeller Capital Management L.P. raised its stake in shares of Indivior by 512.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,286 shares of the company’s stock worth $46,000 after acquiring an additional 1,076 shares in the last quarter. TD Waterhouse Canada Inc. purchased a new stake in Indivior during the second quarter valued at approximately $63,000. GAMMA Investing LLC purchased a new stake in Indivior during the second quarter valued at approximately $66,000. Finally, Kemnay Advisory Services Inc. purchased a new stake in Indivior during the fourth quarter valued at approximately $155,000. 60.33% of the stock is owned by hedge funds and other institutional investors.

Indivior Price Performance

INDV stock opened at $35.82 on Friday. Indivior has a 1-year low of $22.56 and a 1-year high of $42.81. The business has a 50-day moving average price of $37.12 and a 200 day moving average price of $36.23. The company has a market capitalization of $4.23 billion, a P/E ratio of 12.84 and a beta of 0.82.

Indivior (NASDAQ:INDV) last issued its earnings results on Tuesday, June 30th. The company reported $5.75 earnings per share (EPS) for the quarter. The company had revenue of $343.00 million for the quarter. Indivior had a net margin of 26.65% and a negative return on equity of 283.11%. On average, analysts anticipate that Indivior will post 3.66 earnings per share for the current fiscal year.

Indivior Announces Dividend

The business also recently declared a special dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 30th will be issued a $8.13 dividend. The ex-dividend date is Friday, October 30th.

Indivior Company Profile

Indivior plc is a specialty pharmaceutical company focused on developing and commercializing medicines for addiction and serious mental health disorders. Its portfolio is primarily centered on treatments for opioid use disorder, with an emphasis on products designed to support recovery, reduce illicit opioid use and address the risk of overdose.

The company’s key products include SUBOXONE sublingual film, a buprenorphine-and-naloxone treatment for opioid use disorder; SUBLOCADE, a long-acting injectable form of buprenorphine; and OPVEE, a nalmefene nasal spray intended for the emergency treatment of opioid overdose.